Former Genentech CEO takes chairman's role at Apple

Apple picked biotech pioneer Art Levinson as its new non-executive chairman. What's the common denominator at Genentech, where he's still chairman, and the electronics giant? Innovation. Report

Suggested Articles

Monday, Bernstein analysts echoed what many were probably thinking about Novo Nordisk’s Rybselsus price: “Finally we can stop talking about it.”

Low interest rates and strong stock valuations are two top reasons why U.S. drugmakers are on the move for deals.

Despite a 45% premium offered to Allergan investors through the AbbVie buyout, one investor is suing to block the deal.